[Effect of carboxymethyldextran-modified native pancreatic protease-inhibitor on the course of experimental acute pancreatitis].
D000208:Acute Disease; D000818:Animals; D007611:Aprotinin; D003911:Dextrans / Q000627:therapeutic use*; D004285:Dogs; D005260:Female; D008297:Male; D010195:Pancreatitis / Q000188:drug therapy*; D014361:Trypsin Inhibitors / Q000627:therapeutic use*
D003911:Dextrans; D014361:Trypsin Inhibitors; C011475:gordox; C014392:carboxymethyl dextran; D007611:Aprotinin
Vliianie nativnogo pankreaticheskogo ingibitora proteaz, modifitsirovannogo karboksimetildekstranom, na techenie ostrogo pankreatita v éksperimente.